Personal care composition

By using specific weight ratios of tranexamic acid and mandelic acid in personal care compositions, combined with pyruvate and other acids, the problem of skin pigmentation and uniformity is solved, effective melanin reduction and collagen growth are achieved, significantly improving Skin shine and acne-induced pigmentation.

CN119095577APending Publication Date: 2024-12-06COLGATE PALMOLIVE CO
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380036343.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-04-29
Filing Date
2023-04-24
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The prior art is difficult to effectively reduce skin pigmentation and achieve skin pigment uniformity, and the effects of traditional decolorizing products are limited.

Method used

Provided is a personal care composition containing tranexamic acid and mandelic acid in a specific weight ratio of about 1:6 to about 1:17, formulated to contain about 0.1% to about 10% by weight of tranexamic acid, about 0.1% to about 10% by weight of tranexamic acid, about 2% to about 20% by weight mandelic acid, about 0.5% to about 10% by weight sodium pyruvate, and optionally lactic acid, maleic acid and other acids for reducing melanin production and promoting collagen growth.

Benefits of technology

Significantly reduces skin melanin concentration, improves skin pigment uniformity, enhances skin gloss, reduces acne-induced post-inflammatory pigmentation and acne, and is highly safe.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119095577A_ABST
    Figure CN119095577A_ABST
Patent Text Reader

Abstract

Disclosed herein are personal care compositions, and in particular, personal care compositions for depigmenting keratin materials. The personal care composition typically comprises tranexamic acid and mandelic acid, wherein the weight ratio of tranexamic acid to mandelic acid of the personal care composition is from about 1: 6 to about 1: 17.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This application claims the benefit of priority to U.S. Provisional Application No. 63 / 336,703, filed on April 29, 2022, and entitled “PERSONAL CARE COMPOSITIONS,” the contents of which are hereby incorporated herein in their entirety for all purposes. Background Art

[0003] The color of human skin is mainly determined by the properties and concentration of the pigment (melanin). There are two types of melanin in epidermal cells, namely eumalanin, which is a brown-black pigment, and pheomelanin, which is a yellow-orange pigment. Melanin is synthesized by special dendritic cells called melanocytes located in the basal layer of the epidermis. Melanogenesis, the formation of melanin, occurs in special organelles loaded with melanin, the melanosomes, which are transferred to neighboring epidermal cells, the keratinocytes, via dendrites.

[0004] The mechanism of melanogenesis is complex and schematically includes the following major steps: conversion of tyrosine to DOPA, conversion of DOPA to DOPAQUINONE, conversion of DOPAQUINONE to DOPACHROME, and conversion of DOPACHROME to melanin. Inside the melanosomes, three enzymes, namely tyrosinase, Tyrp1 (for tyrosinase-related protein 1) and Dct / Tyrp2 (for DOPACHROMELAN tautomerase / tyrosinase-related protein 2), play a major role in melanogenesis. More specifically, tyrosinase is an essential enzyme that regulates the early steps of eumelanin and pheomelanin synthesis. Pigmentation of the skin of the face and / or body depends on a variety of factors, such as environmental factors associated with the season of the year and the origin of the individual.

[0005] Additionally, at different times in a person's life, darker and / or darker spots may develop, making the skin uneven. For example, pigmentation spots (also known as sun spots) may develop on a person's hands. These spots are often due to high melanin concentrations in the skin. Some people do not like pigmentation spots or their skin's uneven color, and therefore, there remains a need for depigmenting products for the skin. Summary of the invention

[0006] Summary of the invention is only intended to introduce a brief overview of some aspects of one or more embodiments of the present disclosure. Other applicable fields of the present disclosure will become apparent from the detailed description provided below. Summary of the invention is not an exhaustive overview, nor is it intended to identify the key elements or important elements of this teaching, nor is it intended to delimit the scope of the present disclosure. On the contrary, its purpose is only to present one or more concepts in a simplified form as a preface to the following detailed description.

[0007] According to one aspect of the present invention, a personal care composition is provided, comprising tranexamic acid and mandelic acid, wherein the weight ratio of tranexamic acid to mandelic acid of the personal care composition is from about 1:6 to about 1:17. In some embodiments, the personal care composition is formulated such that the weight ratio of tranexamic acid to mandelic acid is from about 1:7 to about 1:12.

[0008] According to another aspect, a personal care composition is provided, having from about 0.1% to about 10% by weight of tranexamic acid; from about 2% to about 20% by weight of mandelic acid; from about 0.5% to about 10% by weight of sodium pyruvate; and optionally, from about 1% to about 30% by weight of one or more additional acids selected from lactic acid, maleic acid, succinic acid, formic acid, propionic acid, butyric acid, isobutyric acid, 2-methylpropionic acid, valeric acid, derivatives thereof, and combinations of two or more thereof, wherein all weight percentages are based on the total weight of the personal care composition. The weight ratio of tranexamic acid to mandelic acid of the personal care composition is typically from about 1:6 to about 1:17. BRIEF DESCRIPTION OF THE DRAWINGS

[0009] Embodiments of the present technology will now be described, by way of example only, with reference to the accompanying drawings, in which:

[0010] Figure 1 is a bar graph of melanin reduction in skin explants seven days after a single application of two comparative compositions or one of the non-limiting exemplary compositions according to aspects of the present invention;

[0011] Figure 2 is a bar graph of collagen produced in skin explants seven days after a single application of two comparative compositions or one of the non-limiting exemplary compositions according to aspects of the present invention;

[0012] Figure 3 is a bar graph of mRNA levels of TYR, TYRP1, and DCT in skin explants seven days after a single application of two comparative compositions or one of the non-limiting exemplary compositions according to aspects of the present invention;

[0013] Figure 4 is a bar graph of the binding affinities of compositions comprising tranexamic acid in combination with mandelic acid, lactic acid or pyruvic acid according to aspects of the present invention;

[0014] Figure 5 is a graph of the binding affinity of certain compounds according to aspects of the present invention to tyrosinase;

[0015] Fig. 6Ais a graph of dermoscopic and vivascope images showing reduction of acne-induced PIH spots and complete closure of three comedones after application of a non-limiting exemplary composition according to aspects of the present invention;

[0016] Figure 6B is a bar graph of the average scores calculated by dermatologists for each subject's objective visual evaluation before and after chemical peeling of a non-limiting exemplary composition according to aspects of the present invention;

[0017] FIG. 7A to FIG. 7D are graphs of microbiome and microbiome changes after application of a non-limiting exemplary composition according to aspects of the present invention; and

[0018] Figure 8 is a bar graph illustrating the synergistic effect achieved by the combination of mandelic acid, lactic acid, and pyruvic acid according to aspects of the present invention.

[0019] It should be understood that the various aspects are not limited to the compositions, compounds and instrumentalities shown in the drawings. DETAILED DESCRIPTION

[0020] For the purpose of illustration, the principle of the present invention is described by reference to multiple exemplary embodiments of the present invention. Although certain embodiments of the present invention are specifically described herein, it will be readily appreciated by those of ordinary skill in the art that the same principles are equally applicable to other compositions and methods and can be used in other compositions and methods. Before describing the disclosed embodiments of the present invention in detail, it should be understood that the present invention is not necessarily limited to the details of any particular embodiment disclosed in terms of its application. The terms used herein are for the purpose of description rather than limitation.

[0021] As used herein and in the appended claims, the singular forms "a," "an," and "the" include plural references unless the context dictates otherwise. The singular form of any class of components refers not only to one chemical substance within that class, but also to mixtures of these chemical substances. The terms "a" (or "an"), "one or more," and "at least one" may be used interchangeably herein. The terms "comprising," "including," and "having" may be used interchangeably. The term "including" should be interpreted as "including, but not limited to." The term "comprising" should be interpreted as "including, but not limited to."

[0022] As used throughout, ranges are used as shorthand for describing individual values ​​and each value within the range. Any value within the range can be selected as the endpoint of the range. Therefore, a range of 1 to 5 specifically includes 1, 2, 3, 4, and 5, and subranges such as 2 to 5, 3 to 5, 2 to 3, 2 to 4, 1 to 4, etc. When referring to a number, the term "about" means any number within 10% of the number. For example, the phrase "about 2.0 wt %" refers to a number between and including 1.8 wt % and 2.2 wt %.

[0023] All references cited herein are hereby incorporated by reference in their entirety. In the event of a conflict in a definition in the present disclosure and that of a cited reference, the present disclosure controls.

[0024] Unless otherwise indicated, the abbreviations and symbols used herein have their ordinary meanings. The abbreviation "wt%" means the percentage by weight relative to the personal care composition. The symbol "μL" means microliter or 10 -6 The symbol "°" means a degree, such as a temperature or an angle. The symbols "h", "min", "mL", "nm", "μm" mean hour, minute, milliliter, nanometer and micrometer, respectively. The abbreviation "UV-VIS" as used in reference to a spectrometer or spectroscopy means ultraviolet-visible. The abbreviation "rpm" means revolutions per minute.

[0025] The phrase "MRS agar" refers to De Man, Rogosa and Sharpe agar, which is a selective medium designed to favor the growth of lactobacilli. The phrase "TSB medium" refers to tryptic soy broth or trypticase soy broth used as a culture broth in microbiology laboratories to grow aerobic bacteria. The phrase "PBS wash" refers to phosphate buffered saline wash. The abbreviation "qPCR" is quantitative polymerase chain reaction.

[0026] When referring to chemical structures and names, the symbols "C", "H", and "O" mean carbon, hydrogen, and oxygen, respectively. The symbols "-", "=", and "≡" mean single, double, and triple bonds, respectively. For readability purposes, chemical functional groups are presented in their adjective form; for each adjective, it is assumed that the word "group" is used. For example, the adjective "alkyl" without a noun following it should be read as "alkyl group".

[0027] Any member of a species list used to exemplify or define a genus may be mutually distinct from, overlap with, be a subset of, be equivalent to, be nearly identical to, or be identical to any other member of the species list, or be identical to any other member of the species list. Furthermore, unless explicitly stated, such as when reciting Markush groups, a species list defining or exemplifying a genus is open-ended, and there may be other species that define or exemplify the genus as well as or better than any other species listed.

[0028] All components and elements that are positively set forth in the present disclosure may be negatively excluded from the claims. In other words, the personal care composition of the present disclosure may be free of or substantially free of all components and elements that are positively stated throughout the present disclosure. In some cases, the personal care composition of the present disclosure may be substantially free of the ingredients or compounds described herein in an unincident amount. The unincident amount of an ingredient or compound is the amount of the ingredient or compound added to the personal care composition alone. For example, the personal care composition may be substantially free of an unincident amount of an ingredient or compound, although such an ingredient or compound may exist as part of a raw material included in a blend of two or more compounds. Unless otherwise defined or described herein, substantially free generally refers to an ingredient or compound that is about 2% by weight or less, about 1.5% by weight or less, about 1% by weight or less, about 0.5% by weight or less, about 0.1% by weight or less, or about 0.05% by weight or less, or about 0.01% by weight or less, based on the total weight of the personal care composition on a dry matter basis.

[0029] Some of the various categories of components identified may overlap. In the event that there may be overlap and the personal care composition comprises two components (or the composition comprises more than two overlapping components), the overlapping compounds do not represent more than one component. For example, certain components or ingredients may be characterized as including both a pH adjuster and an acid having 1 to 6 carbon atoms. If a particular personal care composition lists both a pH adjuster and an alpha hydroxy acid, a compound that may be characterized as both a pH adjuster and an alpha hydroxy acid (e.g., citric acid) would only act as a pH adjuster or an alpha hydroxy acid—not both.

[0030] Aspects of the present invention relate to personal care compositions, and in particular, personal care compositions useful for reducing skin pigmentation and / or promoting uniformity of skin pigmentation. The inventors have recognized that there remains a need for improved compositions for depigmenting keratinous materials, especially the skin, which also allow for improved uniformity of skin tone and restoration of radiance to the complexion. The inventors have discovered that certain combinations of ingredients in specific weight ratios enable personal care compositions to be formulated to provide enhanced pigment reduction and / or elimination while increasing collagen growth.

[0031] According to a first aspect of the present invention, there is provided a personal care composition comprising tranexamic acid and mandelic acid, wherein the weight ratio of tranexamic acid to mandelic acid of the personal care composition is from about 1:6 to about 1:17.

[0032] The personal care composition can be formulated so that the weight ratio of tranexamic acid to mandelic acid is from about 1:6 to about 1:14, from about 1:6 to about 1:12, from about 1:6 to about 1:10, from about 1:6 to about 1:8; from about 1:7 to about 1:14, from about 1:7 to about 1:12, from about 1:7 to about 1:10, from about 1:7 to about 1:8; from about 1:8 to about 1:14, from about 1:8 to about 1:12, from about 1:8 to about 1:10, from about 1:6 to about 1:9; from about 1:9 to about 1:14, from about 1:9 to about 1:12, from about 1:9 to about 1:10; from about 1:10 to about 1:14, from about 1:10 to about 1:12; from about 1:11 to about 1:14, from about 1:11 to about 1:12, or any range or sub-range thereof.

[0033] The inventor finds that the weight ratio of tranexamic acid and mandelic acid can provide the synergistic and / or enhancing effect benefit beyond expectation.For example, the preferred weight ratio of tranexamic acid and mandelic acid provides the pigment reduction of enhancement compared with the tranexamic acid of similar amount and ratio and lactic acid and / or pyruvic acid.Not limited by any particular theory, the inventor believes that the synergistic and / or enhancing effect benefit realized by tranexamic acid and mandelic acid may be at least partially due to the different sites combination on the important enzyme (for example, human tyrosinase) that tranexamic acid and mandelic acid generate with melanin.

[0034] Additionally or alternatively, the personal care composition can unexpectedly achieve improved results by being formulated to have a specific weight ratio of lactic acid, mandelic acid, and / or pyruvic acid. For example, the personal care composition can be formulated to have a weight ratio of lactic acid to mandelic acid to pyruvic acid (lactic acid:mandelic acid:pyruvic acid) of about 12:6:1 to about 1:1:1, about 6:4:1 to about 1:1:1, about 5:3:1 to about 1:1:1, about 4:2:1 to about 1:1:1; about 12:6:1 to about 2:1.5:1, about 6:4:1 to about 2:1.5:1, about 5:3:1 to about 2:1.5:1, about 4:2:1 to about 2:1.5:1; about 12:6:1 to about 3:1.75:1, about 6:4:1 to about 3:1.75:1, about 5:3:1 to about 3:1.75:1, about 4:2:1 to about 3:1.75:1, or any range or sub-range thereof. Without being bound by any particular theory, it is believed that the combination of at least two of lactic acid, mandelic acid, and pyruvic acid may result in the unexpected effect of promoting penetration of tranexamic acid through the skin barrier.

[0035] In certain embodiments, the personal care composition can be formulated such that the weight ratio of the alpha hydroxy acid (lactic acid and / or mandelic acid) to the keto acid (e.g., pyruvic acid) is from about 12:1 to about 1:1. For example, the personal care composition can be formulated such that the weight ratio of the total amount of the alpha hydroxy acid (lactic acid and / or mandelic acid) to the total amount of the keto acid (e.g., pyruvic acid) is from about 10:1 to about 1:1, from about 8:1 to about 1:1, from about 7:1 to about 1:1, from about 6:1 to about 1:1, from about 5:1 to about 1:1, from about 4:1 to about 1:1; from about 12:1 to about 3:1, from about 10:1 to about 3:1, from about 8:1 to about 3:1, from about 7:1 to about 1:1, from about 6:1 to about 1:1, from about 5:1 to about 1:1, from about 4:1 to about 1:1; 0:1 to about 4:1, about 8:1 to about 4:1, about 7:1 to about 4:1, about 6:1 to about 4:1, about 5:1 to about 4:1; about 12:1 to about 5:1, about 10:1 to about 5:1, about 8:1 to about 5:1, about 7:1 to about 5:1, about 6:1 to about 5:1; about 12:1 to about 6:1, about 10:1 to about 6:1, about 8:1 to about 6:1, about 7:1 to about 6:1; about 12:1 to about 7:1, about 10:1 to about 7:1, about 8:1 to about 7:1, or any range or sub-range thereof.

[0036] In some cases, the personal care composition can be free or substantially free of hydroquinone. In some cases, the personal care composition comprises hydroquinone in an amount of about 3 wt % or less, about 2 wt % or less, about 1 wt % or less, about 0.5 wt % or less, about 0.1 wt % or less, or about 0.05 wt % or less, based on the total weight of the personal care composition. In at least one embodiment, the personal care composition is free of hydroquinone.

[0037] Additionally or alternatively, the personal care composition can have a reduced amount of resorcinol and / or its derivatives, be substantially free of or free of resorcinol and / or its derivatives. In some cases, the amount of resorcinol and / or its derivatives in the personal care composition is about 5 wt % or less, about 4 wt % or less, about 3 wt % or less, about 2 wt % or less, about 1 wt % or less, about 0.5 wt % or less, about 0.1 wt % or less, or about 0.05 wt % or less, based on the total weight of the personal care composition. However, in at least one embodiment, the personal care composition comprises resorcinol and / or its derivatives in an amount of about 0.1 wt % to about 5 wt %, about 0.1 wt % to about 3 wt %, about 0.1 wt % to about 1 wt %, about 1 wt % to about 5 wt %, about 1 wt % to about 3 wt %, or any range or sub-range thereof, based on the total weight of the personal care composition.

[0038] In some cases, the personal care composition can be free or substantially free of kojic acid. For example, the personal care composition can include kojic acid in an amount of about 3 wt % or less, about 2 wt % or less, about 1 wt % or less, about 0.5 wt % or less, about 0.1 wt % or less, or about 0.05 wt % or less, based on the total weight of the personal care composition. In at least one embodiment, the personal care composition is free of kojic acid.

[0039] According to the specific combination of other ingredients and the form of the personal care composition, suitable components such as those listed below may be included in the preparation for the personal care composition or may be excluded from the preparation for the personal care composition. The personal care composition can be formulated for hair care, skin care and / or sunscreen care. In some embodiments, the personal care composition is applied to the skin or scalp of the person. The example of the personal care composition includes antiperspirants, deodorants, shower gels, shower gels, lotions, bar soaps, soft soaps, shampoos, conditioners, sunscreens, strippers (e.g., chemical strippers) and cosmetics. The personal care composition can be classified and regulated by national or international regulatory agencies as cosmetics or as drugs.

[0040] As described above, the personal care composition comprises tranexamic acid and mandelic acid, preferably in a specific weight ratio. Based on the total weight of the personal care composition, tranexamic acid can be present in the personal care composition in an amount of about 0.1 wt % to about 10 wt %. For example, the personal care composition can include tranexamic acid in an amount of about 0.1 wt % to about 8 wt %, about 0.1 wt % to about 6 wt %, about 0.1 wt % to about 5 wt %, about 0.1 wt % to about 4 wt %, about 0.1 wt % to about 3 wt %, about 0.1 wt % to about 2 wt %, about 0.1 wt % to about 1 wt % based on the total weight of the personal care composition; about 0.5 wt % to about 10 wt %, about 0.5 wt % to about 8 wt %, about 0.5 wt % to about 6 wt %, about 0.5 wt % to about 5 wt %, about 0.5 wt % to about 4 wt %, about 0.1 wt % to about 3 wt %, about 0.1 wt % to about 2 wt %, about 0.1 wt % to about 1 wt %; %; about 1 wt % to about 10 wt %, about 1 wt % to about 8 wt %, about 1 wt % to about 6 wt %, about 1 wt % to about 5 wt %, about 1 wt % to about 4 wt %, about 1 wt % to about 3 wt %, about 1 wt % to about 2 wt %; about 2 wt % to about 10 wt %, about 2 wt % to about 8 wt %, about 2 wt % to about 6 wt %, about 2 wt % to about 5 wt %, about 2 wt % to about 4 wt %; about 3 wt % to about 10 wt %, about 3 wt % to about 8 wt %, about 3 wt % to about 6 wt %, about 3 wt % to about 5 wt %; about 5 wt % to about 10 wt %, about 5 wt % to about 8 wt %; about 7 wt % to about 10 wt %, or any range or sub-range thereof. In at least one embodiment, the amount of tranexamic acid present in the personal care composition can be about 0.7 wt % to about 2 wt %, about 0.7 wt % to about 1.5 wt %, or about 1 wt %, based on the total weight of the personal care composition.

[0041] Mandelic acid can be present in the personal care composition in an amount of about 2% to about 20% by weight, based on the total weight of the personal care composition. In some cases, the amount of mandelic acid present in the personal care composition is about 2% to about 20% by weight, about 2% to about 16% by weight, about 2% to about 12% by weight, about 2% to about 10% by weight, about 2% to about 8% by weight, about 2% to about 6% by weight; about 4% to about 20% by weight, about 4% to about 16% by weight, about 4% to about 12% by weight, about 4% to about 10% by weight, about 4% to about 8% by weight, about 4% to about 6% by weight, based on the total weight of the personal care composition. % to about 6% by weight; about 6% to about 20% by weight, about 6% to about 16% by weight, about 6% to about 12% by weight, about 6% to about 10% by weight, about 6% to about 8% by weight; about 8% to about 20% by weight, about 8% to about 16% by weight, about 8% to about 12% by weight, about 8% to about 10% by weight; about 10% to about 20% by weight, about 10% to about 16% by weight, about 10% to about 12% by weight, or any range or sub-range thereof. In at least one embodiment, mandelic acid can be present in an amount of about 7% to about 12% by weight, about 7% to about 10% by weight, about 7% to about 9% by weight, or about 8% by weight, based on the total weight of the personal care composition.

[0042] In some embodiments, the personal care composition comprises sodium pyruvate and / or its acid (e.g., pyruvic acid). Based on the gross weight of the personal care composition, the personal care composition may comprise sodium pyruvate and / or its acid in an amount of about 0.5% by weight to about 10% by weight. For example, based on the gross weight of the personal care composition, the total amount of sodium pyruvate and / or its acid present in the personal care composition may be about 0.5% by weight to about 10% by weight, about 0.5% by weight to about 9% by weight, about 0.5% by weight to about 8% by weight, about 0.5% by weight to about 7% by weight, about 0.5% by weight to about 6% by weight, about 0.5% by weight to about 5% by weight, about 0.5% by weight to about 4% by weight, about 0.5% by weight to about 3% by weight; about 1% by weight to about 10% by weight, about 1% by weight to about 9% by weight, about 1% by weight to about 8% by weight, about 1% by weight to about 7% by weight, about 1% by weight to about 6% by weight, about 1% by weight to about 5% by weight, about 1% by weight to about 4 weight %, about 1 weight % to about 3 weight %; about 2 weight % to about 10 weight %, about 2 weight % to about 9 weight %, about 2 weight % to about 8 weight %, about 2 weight % to about 7 weight %, about 2 weight % to about 6 weight %, about 2 weight % to about 5 weight %, about 2 weight % to about 4 weight %; about 3 weight % to about 10 weight %, about 3 weight % to about 9 weight %, about 3 weight % to about 8 weight %, about 3 weight % to about 7 weight %, about 3 weight % to about 6 weight %; about 4 weight % to about 10 weight %, about 4 weight % to about 9 weight %, about 4 weight % to about 8 weight %, about 4 weight % to about 7 weight %, about 4 weight % to about 6 weight %, including any ranges or sub-ranges thereof.

[0043] In some cases, the personal care composition comprises one or more additional acids having a carbon group containing 1 to 6 carbons, for example, in an amount of about 1 wt % to about 30 wt % based on the total weight of the personal care composition. The one or more additional acids having a carbon group containing 1 to 6 carbons can be selected from the formula C n H 2n+1 A hydrocarbyl acid of COOH wherein n is 0 to 6; or an acid substituted with an oxygen-containing group such as an alcohol or an oxo group.

[0044] Examples of additional acids having a carbon group containing 1 to 6 carbons include formic acid, methanoic acid, HCOOH, acetic acid, mandelic acid; ethanoic acid, CH3COOH, propionic acid, CH3CH2COOH, butyric acid, butanoic acid, CH3CH2CH2COOH, isobutyric acid, 2-methylpropionic acid, (CH3)2CHCOOH, valeric acid, pentanoic acid, CH3CH2CH2COOH, isovaleric acid, 3-methylbutanoic acid, and (CH3)2CHCH2COOH. In some embodiments, the additional acid having a carbon group containing 1 to 6 carbons is selected from the group consisting of lactic acid, pyruvic acid, mandelic acid, succinic acid (e.g., succinic acid), formic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, derivatives thereof, salts thereof (e.g., sodium pyruvate), and combinations of two or more thereof. In certain embodiments, the one or more additional acids are selected from: lactic acid; pyruvic acid; mandelic acid; succinic acid; derivatives thereof; salts thereof; and combinations of two or more thereof.

[0045] Examples of additional acids containing one carbon include methanoic acid, formic acid, and HCOOH.

[0046] Examples of additional acids containing two carbons include ethanoic acid, acetic acid, CH3COOH, trichloroacetic acid, thioacetic acid, oxalic acid, HOOCCOOH, oxoacetic acid, glyoxylic acid, formylformic acid, OHCCOOH, 2-hydroxyacetic acid, glycolic acid, dicarbonic acid, glycolic acid, and HOCH2COOH.

[0047] Examples of additional acids containing three carbon atoms include propionic acid, ethanecarboxylic acid, CH3CH2COOH, prop-2-enoic acid, acrylic acid, acroleic acid, vinylcarboxylic acid, propene acid, vinylformic acid, CH2=CH-COOH, 2-propynoic acid, propiolic acid, acetylenecarboxylic acid, propargylicacid, CH≡C-COOH, malonic acid, malonic acid, methanedicarboxylic acid, HOOC-CH2-COOH, 2-hydroxymalonic acid, malonic acid, hydroxymalonic acid, HOOC-CHOH-COOH, oxomalic acid, pyruvic acid, ketomalonic acid, HOOC-CO-COOH, 2,2-dihydroxymalonic acid, dihydroxymalonic acid, pyruvic acid monohydrate, HOOC-C(OH)2-COOH, 2-oxopropionic acid, pyruvic acid acid), α-ketopropionic acid, acetylformic acid, pyroracemic acid, CH3-CO-COOH, 2-hydroxypropionic acid, lactic acid, milk acid, CH3-CHOH-COOH, 3-hydroxypropionic acid, hydroxypropionic acid, CH2OH-CH2-COOH, 2,3-dihydroxypropionic acid, glyceric acid, CH2OH-CHOH-COOH, 2-oxiranecarboxylic acid and epoxypropionic acid.

[0048] Examples of additional acids containing four carbons include butanoic acid, butyric acid, propanecarboxylic acid, CH3(CH2)2COOH, 2-methylpropionic acid, isobutyric acid, isobutanoic acid, (CH3)2CHCOOH, 2-oxobutyric acid, α-ketobutyric acid, CH3-CH2-CO-COOH, 3-oxobutyric acid, acetoacetic acid, CH3CO-CH2-COOH, 4-oxobutyric acid, succinic semialdehyde, HC(O)-CH2-CH2-COOH, (E)-butenedioic acid, fumaric acid, trans-1,2-ethylenedicarboxylic acid, 2-butenedioic acid, trans-butenedioic acid, fumaric acid, boletic acid, donitic acid, lichenic acid, HOOC-CH=CH-COOH, (Z)-butenedioic acid, maleic acid, acid), cis-butenedioic acid, maleic acid, toxilic acid, HOOC-CH=CH-COOH, oxobutanedioic acid, oxaloacetic acid, oxoacetic acid, oxosuccinic acid, HOOC-CH2-CO-COOH, hydroxybutanedioic acid, malic acid, hydroxybutanedioic acid, HOOC-CH2-CHOH-COOH, 2,3-dihydroxybutanedioic acid, tartaric acid, 2,3-dihydroxysuccinic acid, L-tartaric acid, racemic acid, oubenic acid, p-tartaric acid, HOOC(CHOH)2COOH, (E)-but-2-enoic acid, crotonic acid, trans-2-butenoic acid, β-methylacrylic acid, 3-methylacrylic acid, (E)-2-butenoic acid, and CH3-CH=CH-COOH.

[0049] Examples of additional acids containing five carbons include pentanoic acid, valeric acid, valeric acid, butane-1-carboxylic acid, CH3(CH2)3COOH, 3-methylbutyric acid, isovaleric acid, (CH3)2CH-CH2-COOH, pentanedioic acid, glutaric acid, propane-1,3-dicarboxylic acid, 1,3-propanedicarboxylic acid, n-pyrotartaric acid, HOOC-(CH2)3-COOH, 2-oxoglutaric acid, α-ketoglutaric acid, 2-ketoglutaric acid, α-ketoglutaric acid, 2-oxoglutaric acid, oxoglutaric acid, and HOOC-(CH2)2-CO-COOH.

[0050] In some embodiments, one or more other acids with carbon groups comprising 1 to 6 carbons are selected from lactic acid, pyruvic acid, maleic acid, succinic acid, formic acid, propionic acid, butyric acid, isobutyric acid, 2-methylpropionic acid, valeric acid, isovaleric acid, pentanoic acid, derivatives thereof, and combinations of two or more thereof. For example, in one embodiment, one or more other acids with carbon groups comprising 1 to 6 carbons are selected from lactic acid, pyruvic acid, maleic acid, succinic acid, butyric acid, derivatives thereof, and combinations of two or more thereof. In another embodiment, one or more other acids with carbon groups comprising 1 to 6 carbons are selected from lactic acid, pyruvic acid, maleic acid, derivatives thereof, and combinations of two or more thereof. In yet another embodiment, the personal care composition comprises lactic acid, optionally, comprising lactic acid in an amount of about 1 wt % to about 30 wt % based on the gross weight of the personal care composition.

[0051] Lactic acid is a carboxylic acid having the formula CH3-CH(OH)-COOH. According to one embodiment, the lactic acid is L-(+)-lactic acid or (S)-lactic acid. According to another embodiment, the lactic acid is D-(-)-lactic acid or (R)-lactic acid. According to yet another embodiment, the lactic acid is a mixture of two stereoisomers.

[0052] The personal care composition can include a monohydric alcohol, such as those having 1 to 8 carbons. The amount of the monohydric alcohol in the personal care composition can be from about 5% to about 50% by weight, based on the total weight of the personal care composition. For example, based on the total weight of the personal care composition, the personal care composition can include one or more monohydric alcohols in the following amounts: from about 5% to about 45% by weight, from about 5% to about 40% by weight, from about 5% to about 38% by weight, from about 5% to about 36% by weight, from about 5% to about 34% by weight, from about 5% to about 32% by weight, from about 5% to about 30% by weight, from about 5% to about 28% by weight, from about 5% to about 26% by weight; from about 10% to about 50% by weight. %, about 10 wt % to about 45 wt %, about 10 wt % to about 40 wt %, about 10 wt % to about 38 wt %, about 10 wt % to about 36 wt %, about 10 wt % to about 34 wt %, about 10 wt % to about 32 wt %, about 10 wt % to about 30 wt %, about 10 wt % to about 28 wt %, about 10 wt % to about 26 wt %; about 15 wt % to about 50 wt %, about 15 wt % to about 45 wt %, about 15 wt % to about 40 wt %, about 15 % to about 38 wt %, about 15 wt % to about 36 wt %, about 15 wt % to about 34 wt %, about 15 wt % to about 32 wt %, about 15 wt % to about 30 wt %, about 15 wt % to about 28 wt %; about 20 wt % to about 50 wt %, about 20 wt % to about 45 wt %, about 20 wt % to about 40 wt %, about 20 wt % to about 38 wt %, about 20 wt % to about 36 wt %, about 20 wt % to about 34 wt %, about 20 wt % to about From about 32 wt %, from about 20 wt % to about 30 wt %; from about 25 wt % to about 50 wt %, from about 25 wt % to about 45 wt %, from about 25 wt % to about 40 wt %, from about 25 wt % to about 38 wt %, from about 25 wt % to about 36 wt %, from about 25 wt % to about 34 wt %; from about 30 wt % to about 50 wt %, from about 30 wt % to about 45 wt %, from about 30 wt % to about 40 wt %, from about 30 wt % to about 38 wt %, or any range or sub-range thereof.

[0053] Non-limiting examples of monohydric alcohols include methanol, CH3OH, ethanol, CH3CH2OH, n-propanol, 1-propanol, CH3-CH2-CH2-OH, isopropanol, 2-propanol, (CH3)2CH-OH, n-butanol, 1-butanol, CH3-CH2-CH2-CH2-OH, sec-butanol, 2-butanol, CH3-CH2-CHOH-CH3, isobutanol, (CH3)2CH-CH2-OH, tert-butanol, (CH3)3C-OH, n-pentanol, 1-pentanol, CH3-(CH2)4OH, isobutylcarbinol, 3-methylbutan-1-ol, isoamyl alcohol, alcohol), isopentanol, (CH3)2CH-CH2-CH2-OH, active amyl alcohol, 2-methylbutan-1-ol, CH3-CH2-C(CH3)H-CH2-OH, tert-butyl methanol, 2,2-dimethylpropan-1-ol, neopentyl alcohol, (CH3)3C-CH2-OH, 3-pentanol, pentan-3-ol, (CH3-CH2)CH-OH, methyl propyl methanol, pentan-2-ol, CH3-CH2-CH2-CH(OH)-CH3, methyl isopropyl methanol, 3-methylbutan-2-ol, (CH3)2CH-C(OH)-CH3, dimethyl ethyl methanol, 2-methylbutan-2-ol and tert-pentanol, CH3-CH2-C(CH3)2-OH.

[0054] Additionally or alternatively, the personal care composition can include one or more polyols, such as in an amount from about 0.1 wt % to about 20 wt %, based on the total weight of the personal care composition. For example, the amount of polyol present in the personal care composition can be from about 0.1 wt % to about 15 wt %, from about 0.1 wt % to about 10 wt %, from about 0.1 wt % to about 8 wt %, from about 0.1 wt % to about 6 wt %, from about 0.1 wt % to about 5 wt %, from about 0.1 wt % to about 4 wt %, from about 0.1 wt % to about 3 wt %, from about 0.1 wt % to about 2 wt %, from about 0.1 wt % to about 1 ... ; about 0.5 wt % to about 20 wt %, about 0.5 wt % to about 15 wt %, about 0.5 wt % to about 10 wt %, about 0.5 wt % to about 8 wt %, about 0.5 wt % to about 6 wt %, about 0.5 wt % to about 5 wt %, about 0.5 wt % to about 4 wt %, about 0.5 wt % to about 3 wt %, about 0.5 wt % to about 2 wt %, about 0.5 wt % to about 1 wt %; about 1 wt % to about 20 wt %, about 1 wt % to about about 15 wt %, about 1 wt % to about 10 wt %, about 1 wt % to about 8 wt %, about 1 wt % to about 6 wt %, about 1 wt % to about 5 wt %, about 1 wt % to about 4 wt %, about 1 wt % to about 3 wt %, about 1 wt % to about 2 wt %; about 3 wt % to about 20 wt %, about 3 wt % to about 15 wt %, about 3 wt % to about 10 wt %, about 3 wt % to about 8 wt %, about 3 wt % to about 6 wt %; about 5 wt % to about 2 0 weight %, about 5 weight % to about 15 weight %, about 5 weight % to about 10 weight %, about 5 weight % to about 8 weight %; about 7 weight % to about 20 weight %, about 7 weight % to about 15 weight %, about 7 weight % to about 10 weight %; about 9 weight % to about 20 weight %, about 9 weight % to about 15 weight %; about 11 weight % to about 20 weight %, about 11 weight % to about 15 weight %; or about 14 weight % to about 20 weight %, including any ranges or sub-ranges thereof.

[0055] Within the meaning of the present disclosure, the term "polyol" is understood to mean an organic molecule containing at least two free hydroxyl groups. The polyol of the personal care composition can be a diol or a compound having multiple hydroxyl groups. In some cases, one or more polyols are selected from C2-C 32 Polyols. The one or more polyols may be liquid at ambient temperature (25° C.). The one or more polyols may have 2 to 32 carbon atoms, 3 to 16 carbon atoms, or 3 to 12 carbon atoms.

[0056] In some cases, the polyols that can be included in the personal care composition include ethylene glycol, propylene glycol, butylene glycol, hexylene glycol, glycerol, diglycerol, diethylene glycol and dipropylene glycol, and mixtures thereof. In some cases, the polyol is propylene glycol. In some other cases, the polyol is one or both of propylene glycol and butylene glycol. In addition, in some cases, the personal care composition comprises at least propylene glycol, and optionally one or more polyols other than propylene glycol.

[0057] Non-limiting examples of polyols that can be optionally included in the personal care include and / or can be selected from: alkanediols such as glycerol, 1,2,6-hexanetriol, trimethylolpropane, ethylene glycol, propylene glycol, butylene glycol, pentanediol, hexanediol, diethylene glycol, triethylene glycol, tetraethylene glycol, pentaethylene glycol, dipropylene glycol, 2-butene-1,4-diol, 2-ethyl-1,3-hexanediol, 2-methyl-2,4-pentanediol, caprylyl glycol, 1,2-hexanediol, 1,2-pentanediol and 4-methyl-1,2-pentanediol; glycol ethers such as ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monomethyl ... ether, ethylene glycol monobutyl ether, ethylene glycol monomethyl ether acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol mono-n-propyl ether, ethylene glycol monoisopropyl ether, diethylene glycol monoisopropyl ether, ethylene glycol mono-n-butyl ether, ethylene glycol mono-tert-butyl ether, diethylene glycol mono-tert-butyl ether, 1-methyl-1-methoxybutanol, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol mono-tert-butyl ether, propylene glycol mono-n-propyl ether, propylene glycol monoisopropyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol mono-n-propyl ether, dipropylene glycol monoisopropyl ether, sorbitol, sorbitan, glycerol triacetate, and mixtures thereof.

[0058] One or more polyols may optionally be diols or diol ethers, such as monomethyl ether, monoethyl ether and monobutyl ether of ethylene glycol, propylene glycol, or ethers thereof, such as monomethyl ether of propylene glycol, butylene glycol, hexylene glycol, dipropylene glycol, and alkyl ethers of diethylene glycol, such as monoethyl ether or monobutyl ether of diethylene glycol. In some cases, one or more polyols may include or be selected from ethylene glycol, propylene glycol, butylene glycol, hexylene glycol, pentylene glycol, 1,3-propylene glycol, diethylene glycol, dipropylene glycol, 1,4-butylene glycol, 1,5-pentanediol, hexane-1,6-diol, glycerol, diglycerol, caprylyl glycol, and mixtures thereof.

[0059] The personal care composition can include water, for example, in an amount of about 49 wt % or less based on the total weight of the personal care composition. For example, water can be present in the personal care composition in an amount of about 40 wt % or less, about 35 wt % or less, about 30 wt % or less, about 25 wt % or less, about 20 wt % or less, about 15 wt % or less, about 10 wt % or less, about 5 wt % or less, about 4 wt % or less, about 3 wt % or less, about 2 wt % or less, about 1 wt % or less, about 0.5 wt % or less, or about 0.1 wt % or less. In some cases, the personal care composition is formulated to have the following amounts of water, based on the total weight of the personal care composition: from about 1 wt % to about 49 wt %, from about 10 wt % to about 49 wt %, from about 15 wt % to about 49 wt %, from about 20 wt % to about 49 wt %, from about 25 wt % to about 49 wt %, from about 30 wt % to about 49 wt %, from about 35 wt % to about 49 wt %, from about 40 wt % to about 49 wt %; from about 1 wt % to about 45 wt %, from about 10 wt % to about 45 wt %, from about 15 wt % to about 45 wt %, from about 20 wt % to about 45 wt %, from about 25 wt % to about 45 wt %, from about 30 wt % to about 45 wt %, from about 35 wt % to about 45 wt %; from about 1 wt % to about 40 wt %, from about 10 wt % to about 40 wt %, from about 15 wt % to about 40 wt %, from about 20 wt % to about 40 wt %, from about 25 wt % to about From about 1 wt % to about 34 wt %, from about 10 wt % to about 34 wt %, from about 15 wt % to about 34 wt %, from about 20 wt % to about 34 wt %, from about 25 wt % to about 34 wt %; from about 1 wt % to about 31 wt %, from about 10 wt % to about 31 wt %, from about 15 wt % to about 31 wt %, from about 20 wt % to about 31 wt %, from about 25 wt % to about 31 wt %; from about 1 wt % to about 28 wt %, from about 10 wt % to about 28 wt %, from about 15 wt % to about 28 wt %, from about 20 wt % to about 28 wt %, or any range or sub-range thereof.

[0060] The personal care composition may optionally contain a skin conditioning agent. The conditioning agent may be a conditioning oil, such as a hydrocarbon oil, a polyolefin, a fatty ester, a silicone, and the like. In one embodiment, the personal care composition contains from about 0.05% to about 20%, from about 0.08% to about 1.5%, from about 0.1% to about 1% of at least one organic conditioning oil as a conditioning agent, used alone or in combination with other conditioning agents such as silicones. For example, the personal care composition can include one or more skin conditioning agents in an amount of about 0.1 wt % to about 10 wt %, about 0.1 wt % to about 8 wt %, about 0.1 wt % to about 6 wt %, about 0.1 wt % to about 5 wt %, about 0.1 wt % to about 4 wt %, about 0.1 wt % to about 3 wt %, about 0.1 wt % to about 2 wt %, about 0.1 wt % to about 1 wt %; about 0.5 wt % to about 10 wt %, about 0.5 wt % to about 8 wt %, about 0.5 wt % to about 6 wt %, about 0.5 wt % to about 5 wt %, about 0.5 wt % to about 4 wt %, about 0.5 wt % to about 3 wt %, about 0.1 wt % to about 2 wt %, about 0.1 wt % to about 1 wt %; 0.5 wt % to about 1 wt %; about 1 wt % to about 10 wt %, about 1 wt % to about 8 wt %, about 1 wt % to about 6 wt %, about 1 wt % to about 5 wt %, about 1 wt % to about 4 wt %, about 1 wt % to about 3 wt %, about 1 wt % to about 2 wt %; about 2 wt % to about 10 wt %, about 2 wt % to about 8 wt %, about 2 wt % to about 6 wt %, about 2 wt % to about 5 wt %, about 2 wt % to about 4 wt %; about 3 wt % to about 10 wt %, about 3 wt % to about 8 wt %, about 3 wt % to about 6 wt %, about 3 wt % to about 5 wt %; about 5 wt % to about 10 wt %, about 5 wt % to about 8 wt %; about 7 wt % to about 10 wt %, or any range or subrange thereof.

[0061] Non-limiting examples of organic conditioning oils useful as conditioning agents in personal care compositions include, but are not limited to, hydrocarbon oils having at least about 10 carbon atoms, such as cyclic hydrocarbons, straight chain aliphatic hydrocarbons (saturated or unsaturated), and branched chain aliphatic hydrocarbons (saturated or unsaturated), including polymers and mixtures thereof. The straight chain hydrocarbon oil is preferably about C 10. 12 to about C 19. Branched hydrocarbon oils including hydrocarbon polymers will generally contain more than 19 carbon atoms. Specific non-limiting examples of these hydrocarbon oils include paraffin oil, mineral oil, saturated and unsaturated dodecane, saturated and unsaturated tridecane, saturated and unsaturated tetradecane, saturated and unsaturated pentadecane, saturated and unsaturated hexadecane, polybutene, polydecene and mixtures thereof. Branched isomers of these compounds can also be used, as well as branched isomers of higher chain length hydrocarbons, examples of which include highly branched, saturated or unsaturated alkanes, such as permethyl substituted isomers, such as permethyl substituted isomers of hexadecane and eicosane, such as 2,2,4,4,6,6,8,8-dimethyl-10-methylundecane and 2,2,4,4,6,6-dimethyl-8-methylnonane available from Permethyl Corporation; hydrocarbon polymers, such as polybutene and polydecene. Notable hydrocarbon polymers are polybutenes, such as copolymers of isobutylene and butene. A commercially available material of this type is L-14 polybutene from Amoco Chemical Corporation.

[0062] Examples of organic conditioning oils also include liquid polyolefins, such as liquid polyalphaolefins, preferably hydrogenated liquid polyalphaolefins. The polyolefins used herein are obtained by mixing C4 to about C 14 Olefin monomers, such as from about C6 to about C 12 The polyolefin liquids are prepared by polymerization of olefin monomers. Non-limiting examples of olefin monomers for preparing the polyolefin liquids herein include: ethylene, propylene, 1-butene, 1-pentene, 1-hexene to 1-hexadecene, 1-octene, 1-decene, 1-dodecene, 1-tetradecene, branched isomers such as 4-methyl-1-pentene, and mixtures thereof. Also suitable for preparing polyolefin liquids are olefin-containing refinery feedstocks or effluents.

[0063] Other examples of organic conditioning oils used as conditioning agents include, but are not limited to, fatty esters having at least 10 carbon atoms. These fatty esters include esters having a hydrocarbyl chain derived from fatty acids or alcohols (e.g., monoesters, polyol esters, and di- and tri-carboxylates). The hydrocarbyl groups of the fatty esters herein may contain other compatible functional groups (e.g., amides and alkoxy moieties (e.g., ethoxy or ether bonds, etc.)) or have covalently bonded thereto other compatible functional groups (e.g., amides and alkoxy moieties (e.g., ethoxy or ether bonds, etc.)). Specific examples of fatty esters include, but are not limited to, isopropyl isostearate, hexyl laurate, isohexyl laurate, isohexyl palmitate, isopropyl palmitate, decyl oleate, isodecyl oleate, hexadecyl stearate, decyl stearate, dihexyldecyl adipate, lauryl lactate, myristyl lactate, cetyl lactate, oleyl stearate, oleyl oleate, oleyl myristate, lauryl acetate, cetyl propionate, and oleyl adipate. Additional examples of fatty esters include monocarboxylic acid esters of the general formula R'COOR, wherein R' and R are alkyl or alkenyl, and the sum of the carbon atoms in R' and R is at least 10, preferably at least 22. Still other fatty esters include dialkyl and trialkyl esters and alkenyl esters of carboxylic acids, such as esters of C4 to C8 dicarboxylic acids (e.g., C1 to C8 succinic acid, glutaric acid, and adipic acid). 22 Specific non-limiting examples of dialkyl and trialkyl and alkenyl esters of carboxylic acids include isocetylstearyl stearate, diisopropyl adipate and tristearyl citrate.

[0064] Other suitable fatty esters include those known as polyol esters. Such polyol esters include alkylene glycol esters, such as ethylene glycol mono- and di-fatty acid esters, diethylene glycol mono- and di-fatty acid esters, polyethylene glycol mono- and di-fatty acid esters, propylene glycol mono- and di-fatty acid esters, polypropylene glycol monooleate, polypropylene glycol 2000 monostearate, ethoxylated propylene glycol monostearate, glyceryl mono- and di-fatty acid esters, polyglycerol poly-fatty acid esters, ethoxylated monostearate glyceryl, 1,3-butylene glycol monostearate, 1,3-butylene glycol distearate, polyoxyethylene polyol fatty acid esters, sorbitan fatty acid esters, and polyoxyethylene sorbitan fatty acid esters.

[0065] Some further examples of fatty esters include glycerides, including but not limited to monoglycerides, diglycerides and triglycerides, preferably diglycerides and triglycerides, more preferably triglycerides. Glycerides can be glycerol and long-chain carboxylic acids such as C 10 To C 22Monoesters, diesters and triesters of carboxylic acids. Various types of these materials can be obtained from plant and animal fats and oils, such as castor oil, safflower oil, cottonseed oil, corn oil, olive oil, cod liver oil, almond oil, avocado oil, palm oil, sesame oil, lanolin and soybean oil. Synthetic oils include, but are not limited to, triolein and tristearin dilaurin.

[0066] Other fatty esters suitable for use in the compositions of the present invention are water-insoluble synthetic fatty esters. Specific non-limiting examples of suitable synthetic fatty esters for use in the compositions of the present invention include: P-43 (C8-C8 of trimethylolpropane) 10 Triester), MCP-684 (tetraester of 3,3-diethanol-1,5-pentanediol), MCP 121 (C8-C 10 Diesters), all of which are available from Mobil Chemical Company. In one embodiment, the composition comprises ingredients known as emollients and skin feel modifiers. A wide range of skin feel modifiers can be used, such as glycerides and derivatives (excluding fats and oils); alkoxylated alcohols (limited to alkoxylation products of alcohols); ethers (excluding alkoxylated derivatives). In one embodiment, the skin feel modifier is selected from polyglyceryl-3 laurate, PPG-3 isostearyl methyl ether, and PEG-60 almond glycerides.

[0067] The personal care composition may also contain one or more additional ingredients. The CTFA Cosmetic Ingredient Handbook, 10th Edition (published by Cosmetic, Toiletry and Fragrance Association, Inc., Washington, DC) (2004) describes a variety of non-limiting cosmetic and pharmaceutical ingredients commonly used in the skin care industry, which can be used as additional ingredients in the compositions of the present invention. Examples of these ingredient categories include, but are not limited to: repair agents, skin anti-aging agents, skin moisturizers, anti-wrinkle agents, anti-atrophy agents, skin smoothing agents, antibacterial agents, antifungal agents, pesticide antiparasitic agents, antimicrobial agents, anti-inflammatory agents, antipruritic agents, external anesthetics, antiviral agents, keratolytic agents, free radical scavengers, antiseborrheic agents, antidandruff agents, agents that regulate differentiation, hyperplasia or pigmentation of the skin and agents that accelerate penetration, peeling agents, depigmenting agents or pigment promoting agents, anti-glycosylation agents, tightening agents, agents that stimulate the synthesis of dermal or epidermal macromolecules and / or prevent their degradation; stimulating Agents that stimulate the proliferation of fibroblasts and / or keratinocytes or the differentiation of keratinocytes; muscle relaxants; anti-pollution and / or anti-free radical agents; slimming agents, anti-cellulite agents, agents acting on microcirculation; agents acting on the energy metabolism of cells; cleansers, conditioners, hair styling agents, hair growth promoters, sunscreens and / or sunscreen compounds, cosmetics, detergents, pharmaceutical drugs, emulsifiers, emollients, preservatives, deodorant active agents, dermatologically acceptable carriers, surfactants, abrasives, adsorbents, aesthetic components such as fragrances, colorants (colorin gs / colorants), essential oils, skin sensates, cosmetic astringents, anti-acne agents, anti-caking agents, anti-foaming agents, antioxidants, adhesives, biological additives, enzymes, enzymatic inhibitors, enzyme inducers, coenzymes, plant extracts, plant derivatives, plant tissue extracts, plant seed extracts, plant oils, botanicals, botanical extracts, ceramides, peptides, buffers, bulking agents, chelating agents, chemical additives, colorants, cosmetic biocides, denaturants, pharmaceutical astringents, external analgesics, film formers or materials used to assist film forming properties (e.g. Such as polymers), quaternary derivatives, opacifiers, pH adjusters, propellants, reducing agents, chelating agents, skin bleaching and lightening agents, skin tanning agents, skin conditioning agents (such as moisturizers, including mixed and occlusive types), skin soothing and / or healing agents and derivatives, skin therapeutic agents, thickeners, and vitamins and their derivatives, exfoliants, moisturizers, solidifying agents, lignans, preservatives, UV absorbers, cytotoxins, anti-tumor agents, lipid-soluble active agents, suspending agents, viscosity modifiers, dyes, non-volatile solvents, diluents, pearlescent aids, foam boosters, vaccines, and mixtures thereof.

[0068] In some embodiments, the additional ingredient is selected from the group consisting of: sugar amine, glucosamine, D-glucosamine, N-acetyl glucosamine, N-acetyl-D-glucosamine, mannosamine, N-acetyl mannosamine, galactosamine, N-acetyl galactosamine, vitamin B3 and its derivatives, niacinamide, sodium dehydroacetate, dehydroacetic acid and its salts, phytosterols, salicylic acid compounds, hexamidine, dialkanoyl hydroxyproline compounds, soy extracts and derivatives, equol, isoflavones, flavonoids, phytantriol, farnesol, geraniol, peptides and their derivatives, di Peptides, tripeptides, tetrapeptides, pentapeptides and hexapeptides and their derivatives, lys-thr-thr-lys-ser, palmitoyl-lys-thr-thr-lys-ser, carnosine, N-acyl amino acid compounds, retinoids, retinyl propionate, retinol, retinyl palmitate, retinyl acetate, retinal, retinoic acid, water-soluble vitamins, ascorbate, vitamin C, ascorbic acid, ascorbyl glucoside, ascorbyl palmitate, magnesium ascorbyl phosphate, sodium ascorbyl phosphate, vitamins, their salts and derivatives, vitamins benzophenone and its salts and derivatives, ethyl panthenol, vitamin B, vitamin B derivatives, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin K, vitamin K derivatives, pantothenic acid and its derivatives, panthenyl ethyl ether, panthenol and its derivatives, dexpanthenol, biotin, amino acids and their salts and derivatives, water-soluble amino acids, asparagine, alanine, indole, glutamic acid, water-insoluble vitamins, vitamin A, vitamin E, vitamin F, vitamin D, monoterpenes, diterpenes and triterpenes, β-ionol, cedrol and its derivatives , water-insoluble amino acids, tyrosine, tryptamine, butylated hydroxytoluene, butylated hydroxyanisole, allantoin, tocopherol nicotinate, tocopherol, tocopherol esters, palmitoyl-gly-his-lys, phytosterols, hydroxy acids, glycolic acid, lactic acid, lactobionic acid, keto acid, pyruvic acid, phytic acid, lysophosphatidic acid, stilbene, cinnamate, resveratrol, kinetin, zeatin, dimethylaminoethanol, natural peptides, soybean peptides, sugar acid salts, manganese gluconate, zinc gluconate, granular materials, pigment materials, natural pigments, piroctone olamine salts, 3,4,4'-Trichlorocarbanilide, triclocarban, zinc pyrithione, hydroquinone, kojic acid, ascorbic acid, magnesium ascorbyl phosphate, ascorbyl glucoside, pyridoxine, aloe vera, terpene alcohols, allantoin, bisabolol, dipotassium glycyrrhizate, glyceric acid, sorbitic acid, pentaerythritol acid, pyrrolidone acid and its salts, dihydroxyacetone, erythrulose, glyceraldehyde, tartaric aldehyde, clove oil, menthol, camphor, eucalyptus oil, eugenol, menthyl lactate, witch hazel distillate, copolymer of eicosene and vinyl pyrrolidone, iodopropyl butylcarbamate, polysaccharides, essential fatty acids, salicylates, glycyrrhetinic acid, carotenoids, ceramides and pseudoceramides, lipid complexes, general oils of natural origin, such as shea butter, shea butter, apricot oil, evening primrose oil (onagre oil), prunus oil, palm oil, monoi oil (monoi oil), HEPES; procysteine; O-octanoyl-6-D-maltose; disodium salt of methylglycine diacetic acid, steroids, such as diosgenin and derivatives of DHEA; DHEA or dehydroepiandrosterone and / or precursors or chemical or biological derivatives, N-ethoxycarbonyl-4-p-aminophenol, raspberry extract; plant hormones; extracts of the yeast Saccharomyces cerevisiae; algae extracts; extracts of soybean, lupine, corn and / or pea; alverine and its salts, in particular alverine citrate, extracts of Ruscus aculeatus and Horse Chestnut, metalloproteinase inhibitors, and mixtures of two or more thereof.

[0069] The personal care composition may contain a preservative. The preservative may be selected from benzalkonium chloride; benzethonium chloride, 5-bromo-5-nitro-1,3-dichlorobenzene; Alkane; 2-bromo-2-nitropropane-1,3-diol; alkyl trimethyl ammonium bromide; N-(hydroxymethyl)-N-(1,3-dihydroxymethyl-2,5-dioxo-4-imidazolidinyl-N-(hydroxymethyl)urea; 1-3-dihydroxymethyl-5,5-dimethylhydantoin; formaldehyde; iodopropynyl butyl carbamate, butyl p-hydroxybenzoate; ethyl p-hydroxybenzoate; methyl p-hydroxybenzoate; propyl p-hydroxybenzoate, 1: A mixture of methylisothiazolinone / methyl-chloroisothiazolinone in a weight ratio of 3; a mixture of phenoxyethanol / butyl parahydroxybenzoate / methyl parahydroxybenzoate / propyl parahydroxybenzoate; 2-phenoxyethanol, trihydroxyethyl-hexahydrotriazine; methylisothiazolinone; 5-chloro-2-methyl-4-isothiazolin-3-one; 1,2-dibromo-2,4-dicyanobutane; 1-(3-chloroalkyl)-3,5,7-triaza-nitrogen adamantane chloride; an organic acid, lactic acid or citric acid, and combinations of two or more thereof. In one embodiment, the preservative comprises sorbitan caprylate, propylene glycol and benzoic acid, commercially available as Nipaguard SCE. In an embodiment, the one or more preservatives are present in an amount of about 0.25 wt % to 3 wt %, or 0.3 wt % to 2 wt %, or 0.3 wt % to 0.7 wt %, based on the total weight of the personal care composition.

[0070] According to another aspect of the present invention, a method for improving the health and / or appearance of the skin is provided. The method generally comprises applying a personal care composition as disclosed herein, preferably in an effective amount. The method of the present disclosure may comprise applying the personal care composition surface, subcutaneously or transdermally to the skin of a person. Subcutaneous administration may utilize injection, or may be performed using a patch, plaster, microneedle or iontophoresis. Examples of topical administration include applying the personal care composition in the form of a layer (e.g., gel layer) of a cream, lotion, essence, extract or patch.

[0071] In some embodiments, the method includes wounding a skin segment and applying a personal care composition disclosed herein to the wounded skin segment. The personal care composition may be applied before or after wounding the skin. The skin segment may be wounded by means of microneedles, for example, using a microneedle device and procedure known to those of ordinary skill in the art. For example, the method may include applying a personal care composition to a human skin segment, followed by microneedling the skin segment to deliver the personal care composition or a component thereof into or below the stratum corneum. The method may use a microneedle device to pierce the stratum corneum without substantially penetrating the dermis to target the tissue layer below the stratum corneum.

[0072] The microneedle device used in the method can include a plurality of microneedles, which can have a length sufficient to penetrate the stratum corneum. The microneedle can be hollow and / or have a central channel extending through the length of the microneedle for communicating with a syringe barrel, so that the personal care composition can be pressurized through the stratum corneum of the skin. However, in some embodiments, the microneedle is solid.

[0073] In at least one embodiment, the method is iontophoresis and / or includes applying an electric current to the skin. The application of microneedles can reduce the resistance of the stratum corneum, and therefore can greatly reduce the voltage required to promote iontophoresis, thereby improving safety and requiring much less power consumption. By using iontophoresis, certain compounds of personal care can pass through the stratum corneum and enter the thicker dermis, and the combination of two transmission enhancement methods provides an increase in permeability to both the stratum corneum and the deep layers of the skin. In some cases, the transmission improvement in the stratum corneum is mainly due to microneedle puncture, while iontophoresis provides a higher transmission rate in the epidermis and dermis. Microneedle devices and methods of use thereof can be found in U.S. Patent No. 6,623,457, which is incorporated herein by reference in its entirety.

[0074] Example

[0075] Example 1

[0076] A non-limiting exemplary personal care composition (Example Composition A) was prepared according to aspects of the present invention. A comparative composition comprising kojic acid and hydroquinone (Comparative Composition 1) and a positive control composition comprising kojic acid (Comparative Composition 2) were also prepared. The formulations of Example Composition A and Comparative Compositions 1 and 2 are summarized in Table 1 provided below.

[0077] Table 1

[0078]

[0079] Example 2

[0080] Example composition A was evaluated using skin explants compared to comparative composition 1 to evaluate the effect on melanin pigmentation. The skin explants had skin type IV and were obtained from a 40-year-old female donor. Samples from each of Example composition A and comparative composition 1 were applied to the respective skin explants and retained on the respective skin explants for 20 minutes. The explants were then harvested on day 7 for evaluation.

[0081] Skin explants were evaluated by histochemical imaging to determine the level of melanin pigmentation in the skin explants. Specifically, skin explants were stained with Fontana Masson (melanin) and picosirius red (collagen), imaged using brightfield microscopy, and then converted from RGB images to an L*a*b* color scale to quantify melanin and collagen content. Figure 1 As can be seen, Example Composition A achieved a significant reduction in melanin compared to Comparative Composition 1.

[0082] Example 3

[0083] A study was conducted to evaluate the effects of Example Composition A and Comparative Composition 1 on collagen in the skin. Specifically, samples of Example Composition A and Comparative Composition 1 were applied to skin explants according to the procedure described in Example 1, except that the stain used to image the skin explants was specific for collagen imaging. Figure 2 As can be seen, Example Composition A unexpectedly provided improved collagen growth.

[0084] Example 4

[0085] Example composition A was evaluated to evaluate three pigmentation markers (TYR, TYRP1 and DCT) compared to comparative composition 1 and comparative composition 2. Samples from example composition A and comparative composition 1 were applied to respective skin explants. The skin explants had skin type II and were obtained from a 33-year-old female donor. Similar to Example 1, samples of example composition A and comparative composition 1 were applied to skin explants for 20 minutes. The skin explants were then harvested 7 days after application of the respective sample compositions and evaluated.

[0086] The skin explants were then evaluated to determine the levels of three pigmentation markers, TYR, TYRP1, and DCT, in the skin explants. The skin explants were then evaluated using a procedure similar to that described in Example 2, except that RT-qPCR was used to quantify gene expression. The levels of the three gene markers were then normalized to the housekeeping gene ribosomal protein S13. Notably, Example Composition A significantly reduced the levels of TYRP1 and DCT compared to Comparative Compositions 1 and 2. Figure 3 is a bar graph of mRNA levels of TYR, TYRP1, and DCT in skin explants seven days after a single application of two comparative compositions or one of the non-limiting exemplary compositions according to aspects of the present invention;

[0087] Example 5

[0088] Three compositions were prepared to evaluate the binding affinity of tranexamic acid ("TXA") in combination with mandelic acid, lactic acid, or pyruvic acid. Each composition was prepared with the same amount of tranexamic acid and had molar equivalents of mandelic acid, lactic acid, or pyruvic acid relative to each other. Figure 4 As seen, the composition comprising tranexamic acid and mandelic acid had significantly higher binding affinity than the composition comprising tranexamic acid and lactic acid and the composition comprising tranexamic acid and pyruvic acid.

[0089] Example 6

[0090] Example composition A was further evaluated to assess the expression of melanin synthesis gene markers. Specifically, 9 volunteers representing different ethnicities, fitzpatrick skin types (I to V) and skin conditions (photodamage, melasma and acne-induced post-inflammatory pigmentation) were subjected to 2 peeling sessions, 4 weeks apart. A summary of the application and evaluation of Example composition A is provided in Table 2 (below).

[0091] Table 2

[0092]

[0093] There were three measurement periods: before peeling (week 0), 4 weeks after the first peel (week 4), and 4 weeks after the second peel (week 8). Facial images were captured and analyzed from three angles (front, left, and right) using Visia-CR 4.3.1 with special optics and RBX image processing for separation of red from brown. A certified dermatologist rated the overall appearance changes of the volunteers' faces, specifically skin texture, uneven pigmentation, and redness, on a scale of 0 to 4 (0 = none, 1 = minimal, 2 = mild, 3 = moderate, 4 = severe).

[0094] As previously reported, optical biopsies were performed on facial skin using Vivascope 1500 and MPTflex. Specifically, a medical-grade ECG loop was used to monitor the same point during treatment (longitudinal imaging). Skin anatomical images (keratinocytes, melanin, collagen, etc.) were acquired according to the manufacturer's protocol, using tissue caps and conductive gel for vivascope 1500 imaging (830nm laser with a maximum power of 20mW) and magnetic rings with coverslips, oil and water for MPTflex imaging (adjustable laser at 760nm and 890nm with a maximum power of 39mW). Dermoscopic images were also acquired before imaging with vivascope 1500. Vivascope images were primarily used to visualize melanin, while MPTflex images were used to visualize keratinocytes. FLIM images and photon counts were acquired at two different wavelengths (760nm and 890nm) to accurately distinguish NADH from other autofluorescent groups in the skin such as melanin and FAD, and to quantify them. FLIM images were processed offline using SPCImage software from Becker and Hickl GmbH.

[0095] Using a special large profile from Copan Diagnostics, Inc., USA (Cat#528C) was used to swab the cheek. In particular, a sterile swab was used to wipe the entire cheek after dipping the swab applicator in a PBS buffer solution. The cheek was wiped for 30 seconds by applying in a rolling manner and horizontally to ensure that the entire surface area of ​​the cheek was covered to accurately represent the sample. After sample collection, the tip of the swab was cut off and placed in a sterile tube. The swab was immediately stored at a temperature of -80°C until tested for microbial information. 16SrRNA sequencing was performed using a MiSeq device (Illumina), and the data was processed to obtain alpha and beta diversity indices. The two most abundant species, Propionibacterium acnes and Staphylococcus epidermidis, were further analyzed to quantify changes before and after peeling.

[0096] Molecular docking modeling was used to predict the affinity or inhibition of certain compounds against tyrosinase. Specifically, ellagic acid, resorcinol derivatives (butyl > phenylethyl), glabridin and glycyrrhizic acid (commonly found in licorice), and arbutin (a derivative of HQ) showed the greatest binding affinity in our computer screening, with very high binding affinities of less than -6 kcal / mol (see Figure 5 ). Hexylresorcinol, kojic acid (KA), AzA, HQ, TXA, ascorbic acid, and mandelic acid showed moderate activity (affinity of -4 kcal / mol to -6 kcal / mol), while methimazole, TCA, lactic acid, and pyruvic acid showed the least binding affinity, with binding activity weaker than -4 kcal / mol.

[0097] All subjects (N=9) completed the study without adverse events. In most cases where Example Composition A was applied, a significant reduction in brown spots and redness was observed. The reduction in redness and brown spots was even more pronounced after processing the VISIA images using RBX image processing to separate brown from red. A case of acne-induced PIH reported a reaction to sunscreen and was corrected after replacing the sunscreen with a commercial sunscreen designed specifically for oily and acne-prone skin. Fig. 6A are pictures of dermoscopic and vivascope images showing reduction of acne-induced PIH spots and complete closure of three comedones after peeling due to application of Example Composition A. Figure 6B is a bar graph of the average scores calculated by dermatologists for each subject's objective visual evaluation before and after Example Composition A chemical peel.

[0098] In addition, it was determined that in the majority of cases representing different types of common pigmentation that we recruited in our study, Example Composition A provided a reduction in pigmentation, and unexpectedly also provided a reduction in erythema. Based on this unexpected determination, it is expected that Example Composition A may be safe for long-term use, unlike compositions containing HQ and KA, which have risks associated with their long-term use.

[0099] Example 7

[0100] The cheek swab samples from Example 6 were evaluated to assess the microbiome of the volunteers' skin after application of Example Composition A. Specifically, the cheek swab samples (9 subjects x 3 time points = 27) generated more than 10,000 reads after gene sequencing, except for one sample that generated 7342 reads. Fig. 7A The average microbial composition of the facial microbiome evaluated is shown. Propionibacterium acnes was the most abundant, ranging from 14% to 91%, and Staphylococcus epidermidis was 0.5% to 26%. Staphylococcus aureus, commonly associated with infection and atopic dermatitis, was very rare and below the limit of detection, except for two subjects with less than 0.1% abundance. Although there was no significant difference compared to baseline, there was a significant change in species richness after the chemical peel ( Figure 7B ). There were no structural differences (β diversity) in the microbiome before and after stripping ( Figure 7C ). Detailed analysis of the two most abundant species in all nine subjects revealed a significant increase in Staphylococcus epidermidis and a decrease in Propionibacterium acnes, as Fig.7D Unexpectedly, another subject (Fitz skin type IV, Spanish female with severe melasma spots) showed an abnormal abundance of P. acnes of >90% and a significant reduction in porphyrins was observed after Example Composition A peeling.

[0101] Example 8

[0102] Four compositions were prepared to evaluate the effect of a combination of mandelic acid, lactic acid, and pyruvic acid compared to the effect of each of the foregoing acids alone. Specifically, a first pure solution comprising lactic acid was prepared, a second pure solution comprising mandelic acid was prepared, a third pure solution comprising pyruvic acid was prepared, and a fourth pure solution comprising a combination of lactic acid, mandelic acid, and pyruvic acid was prepared, the fourth pure solution having a weight ratio of lactic acid to mandelic acid to pyruvic acid of 4:2:1 and the same amount as the corresponding first, second, and third pure solutions.

[0103] The combination of lactic acid, mandelic acid and pyruvic acid unexpectedly exhibited a synergistic effect. Specifically, the effect achieved by the combination of mandelic acid, lactic acid and pyruvic acid was determined to be about 21.9%, which is about 10 times (1000%) the sum of the effects of the individual additive effects (from the sum of the effects of the three individual acids in their respective amounts). Figure 8 is a bar graph showing the synergistic effect achieved by the combination of mandelic acid, lactic acid and pyruvic acid. The synergistic effect is particularly unexpected in view of the combined activities described in Example 6.

Claims

1. A personal care composition comprising: Tranexamic acid; and Mandelic acid, The personal care composition has a weight ratio of tranexamic acid to mandelic acid of from about 1:6 to about 1:

17.

2. The personal care composition of claim 1, wherein the weight ratio of tranexamic acid to mandelic acid is from about 1:7 to about 1:

12.

3. The personal care composition of claim 1 or claim 2, wherein the tranexamic acid is present in an amount of about 0.1 wt % to about 10 wt %, based on the total weight of the personal care composition.

4. The personal care composition according to any preceding claim, wherein the mandelic acid is present in an amount of about 2 wt. % to about 20 wt. %, based on the total weight of the personal care composition.

5. The personal care composition according to any preceding claim, further comprising sodium pyruvate, optionally in an amount of from about 0.5 wt. % to about 10 wt. % based on the total weight of the personal care composition.

6. The personal care composition of claim 1, further comprising one or more acids having a carbon group containing 1 to 6 carbons, optionally in an amount of about 1 wt % to about 30 wt % based on the total weight of the personal care composition.

7. The personal care composition of claim 6, wherein the one or more acids having a carbon group containing 1 to 6 carbons are selected from lactic acid, pyruvic acid, maleic acid, succinic acid, formic acid, propionic acid, butyric acid, isobutyric acid, 2-methylpropionic acid, valeric acid, isovaleric acid, valeric acid, derivatives thereof, and combinations of two or more thereof.

8. A personal care composition according to claim 6 or claim 7, wherein the one or more acids having a carbon group containing 1 to 6 carbons are selected from lactic acid, pyruvic acid, maleic acid, succinic acid, butyric acid, derivatives thereof, and combinations of two or more thereof.

9. The personal care composition of any one of claims 6 to 8, wherein the one or more acids having a carbon group containing 1 to 6 carbons are selected from lactic acid, pyruvic acid, maleic acid, derivatives thereof, and combinations of two or more thereof.

10. The personal care composition of claim 1, further comprising lactic acid, optionally in an amount of from about 1 wt. % to about 30 wt. % based on the total weight of the personal care composition.

11. The personal care composition according to any preceding claim, wherein the personal care composition comprises less than about 0.5 wt. % resorcinol and / or derivatives thereof, based on the total weight of the personal care composition.

12. A personal care composition according to any preceding claim, wherein the personal care composition is free of resorcinol and / or its derivatives.

13. The personal care composition according to any preceding claim, wherein the personal care composition comprises less than about 1 wt. % hydroquinone, based on the total weight of the personal care composition.

14. A personal care composition according to any preceding claim, wherein the personal care composition is free of hydroquinone.

15. The personal care composition according to any preceding claim, further comprising a monohydric alcohol in an amount from about 5 wt. % to about 50 wt. %, based on the total weight of the personal care composition.

16. The personal care composition according to any preceding claim, further comprising a polyol in an amount from about 0.1 wt. % to about 20 wt. %, based on the total weight of the personal care composition.

17. The personal care composition according to any preceding claim, wherein the personal care composition comprises about 49 wt. % or less water, based on the total weight of the personal care composition.

18. A personal care composition comprising: from about 0.1% to about 10% by weight of tranexamic acid; from about 2 wt % to about 20 wt % mandelic acid; From about 0.5 wt % to about 10 wt % sodium pyruvate; and Optionally, from about 1 wt % to about 30 wt % of one or more additional acids selected from lactic acid, maleic acid, succinic acid, formic acid, propionic acid, butyric acid, isobutyric acid, 2-methylpropionic acid, valeric acid, derivatives thereof, and combinations of two or more thereof, The weight ratio of tranexamic acid to mandelic acid of the personal care composition is from about 1:6 to about 1:17, and all weight percentages are based on the total weight of the personal care composition.

19. The personal care composition of claim 18, wherein the weight ratio of tranexamic acid to mandelic acid is from about 1:7 to about 1:

12.

20. The personal care composition of claim 18, wherein the weight ratio of tranexamic acid to mandelic acid is from about 1:7 to about 1:

10.

21. A personal care composition according to any one of claims 18 to 20, wherein the composition comprises from about 1 wt. % to about 30 wt. % of the one or more additional acids selected from lactic acid, maleic acid, succinic acid, formic acid, propionic acid, butyric acid, isobutyric acid, 2-methylpropionic acid, valeric acid, derivatives thereof, and combinations of two or more thereof.

22. The personal care composition of claim 21, wherein the one or more additional acids are selected from lactic acid, maleic acid, succinic acid, derivatives thereof, and combinations of two or more thereof.

23. The personal care composition of claim 22, wherein the one or more additional acids comprises lactic acid.

24. The personal care composition of any one of claims 18 to 23, wherein the personal care composition comprises less than about 0.5 wt. % of resorcinol and / or its derivatives, based on the total weight of the personal care composition.

25. A personal care composition according to any one of claims 18 to 24, wherein the personal care composition is free of resorcinol and / or its derivatives.

26. The personal care composition of any one of claims 18 to 25, wherein the personal care composition comprises less than about 1 wt. % hydroquinone based on the total weight of the personal care composition.

27. The personal care composition of any one of claims 18 to 26, wherein the personal care composition is free of hydroquinone.

28. The personal care composition of any of the preceding claims, wherein the personal care composition comprises less than about 1 wt. % kojic acid, based on the total weight of the personal care composition.

29. A personal care composition according to any preceding claim, wherein the personal care composition is free of kojic acid.

30. A method for treating, inhibiting or preventing: Abnormal pigmentation of the skin; wrinkle; acne or rosacea; Loss of skin elasticity; Crow's feet; Pigmented lesions (freckles, sun spots, melasma); and / or Photodamage to the skin, The method comprises: A personal care composition according to any preceding claim is applied to the skin surface of a subject in need thereof.

31. A method for: Improve light damage; Reduce or prevent fine lines and wrinkles; Improve uneven skin tone; and / or Improves mottled pigmentation. The method comprises: A personal care composition according to any one of claims 1 to 29 is applied to the skin surface of a subject in need thereof.

32. A method for skin rejuvenation comprising applying any of the personal care compositions described herein (eg, any of claims 1 to 29) to the skin surface of a subject in need thereof.

33. The method of claim 32, wherein the personal care composition is applied to the skin surface after a dermatological procedure.

34. The method of claim 33, wherein the dermatological procedure is selected from the group consisting of: microdermabrasion; ablative laser resurfacing (e.g., with CO2 or erbium); non-ablative resurfacing (e.g., photorejuvenation or pulsed dye laser); microneedling; ultrasound; cryotherapy; radiofrequency; and combinations of two or more thereof.